Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Kahn

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
Diabetes|November 1, 1989
Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?D Porte, S E Kahn
Diabetes|March 29, 2001
beta-cell dysfunction and failure in type 2 diabetes: potential mechanismsD Porte, S E Kahn
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 1, 1995
The key role of islet dysfunction in type II diabetes mellitusD Porte, S E Kahn
The American Journal of Medicine|November 28, 1988
Islet dysfunction in non-insulin-dependent diabetes mellitusS E Kahn, D Porte
The American Journal of Medicine|July 4, 1991
Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an updateD Porte, S E Kahn
Nature|January 6, 2000
Insulin resistance and obesityM W Schwartz, S E Kahn
Experimental and Molecular Pathology|February 1, 1987
Tryptophan distribution and metabolism in experimental chronic renal insufficiencyE W Holmes, S E Kahn
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 30, 1982
Rapid resolution of visual field defects and reduction in macroprolactinoma size with bromocriptine therapy. A case reportS E Kahn, J L Miller
Diabetes|November 14, 1997
Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDMS E Kahn, P A Halban
American Heart Journal|October 1, 1985
Low-dose streptokinase therapy for Swan-Ganz catheter-induced thrombosisS E Kahn, J Goldstein, C Cope
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
Diabetes|November 1, 1989
Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?D Porte, S E Kahn
Diabetes|March 29, 2001
beta-cell dysfunction and failure in type 2 diabetes: potential mechanismsD Porte, S E Kahn
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 1, 1995
The key role of islet dysfunction in type II diabetes mellitusD Porte, S E Kahn
The American Journal of Medicine|November 28, 1988
Islet dysfunction in non-insulin-dependent diabetes mellitusS E Kahn, D Porte
The American Journal of Medicine|July 4, 1991
Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an updateD Porte, S E Kahn
Nature|January 6, 2000
Insulin resistance and obesityM W Schwartz, S E Kahn
Experimental and Molecular Pathology|February 1, 1987
Tryptophan distribution and metabolism in experimental chronic renal insufficiencyE W Holmes, S E Kahn
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 30, 1982
Rapid resolution of visual field defects and reduction in macroprolactinoma size with bromocriptine therapy. A case reportS E Kahn, J L Miller
Diabetes|November 14, 1997
Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDMS E Kahn, P A Halban
American Heart Journal|October 1, 1985
Low-dose streptokinase therapy for Swan-Ganz catheter-induced thrombosisS E Kahn, J Goldstein, C Cope
Pageof 17